Elevated heparinase levels in myeloma and BC cells have also been linked to increased release of syndecan-1, VEGF and hepatocyte growth factor (HGF) in sEVs, resulting in increased endothelial invasion via TME [81]. Here, VEGFA is linked to breast cancer.